Wall Street shuffled its fearful feet on Tuesday, November 18, 2025, as investors digested a buffet of macroeconomic reports, corporate news, and political drama—the kind of day that makes even seasoned traders wish for a stronger coffee and perhaps, a bar of…
Anthropic, the AI shop best known for giving ChatGPT’s Claude a run for its money, has announced a jaw-dropping, spreadsheet-busting $30 billion commitment to Microsoft’s Azure cloud platform—a sum large enough to make even the most seasoned CFO reach for a calculator…
Ondas Holdings (ONDS, $6.84, +166.80% YTD) has officially closed the $225 million deal to acquire Sentrycs, the Israeli cyber-wrangler with a knack for taking over rogue drones—no jamming, no spoofing, just pure protocol manipulation, much to the dismay of any quadcopter plotting…
Intuit’s (INTU) latest splash isn’t in fintech, but in construction—where the budget now garners more buzz than its balance sheet. Yes, the $2 billion figure making headlines isn’t another buyback authorization or a Silicon Valley campus remodel: It’s the sticker price for…
Monday was a classic "hold your horses" day, with Wall Street digesting fresh economic data, tariff news, and awaiting Nvidia’s AI-focused earnings report later this week. Stock indices retreated modestly but maintain strong YTD performance, investors eyeing the yield curve and FOMC…
Blue Origin’s CEO, Dave Limp, has sparked industry attention with his stunningly candid forecast: the world’s biggest AI-optimized data centers will soon decamp from the plains of Utah and the forests of Oregon for the final, distinctly real frontier—outer space. Driven by…
Modular Medical (NASDAQ: MODD) is injecting fresh ambition into the world of diabetes care, touting Institutional Review Board (IRB) approval to deliver insulin with its Pivot™ tubeless patch pump to adult study participants just as the company pursues FDA clearance for commercial…
Johnson & Johnson (JNJ) made headlines with its definitive agreement to acquire Halda Therapeutics, a privately head clinical-stage biotech company famed for its Regulated Induced Proximity Targeting Chimera (RIPTAC) platform, in a $3.05 billion cash deal. The strategic move, set to strengthen…
Opendoor Technologies Inc. (NASDAQ: OPEN), the online real estate platform that once made home flipping look like flipping pancakes, has now flipped its script to become an artificial intelligence-driven enterprise, sending its stock soaring nearly 24% ahead of a special dividend announcement.…
Merck (MRK), ever the discerning giant of Big Pharma, has decided to join the prophylactic party by acquiring Cidara Therapeutics (CDTX) for a headline-grabbing $9.2 billion—a move that whispers both “strategic pipeline expansion” and “Keytruda’s patent clock is ticking, folks.” In a…
